Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (361-370 of 531) with videos related to

Pageof 54
Sort By:
Alcoholism, Clinical and Experimental Research|April 9, 1999
Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis geneP S Haber, M D Norris, M V Apte, et al.
Cardiology in the Young|October 14, 2024
Physical activity in the Fontan population: provider recommendations and patient actionsAlyson R Pierick, Darren Marshall, Sunkyung Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials GroupM E Trudeau, E A Eisenhauer, B P Higgins, et al.
Cancer Research|July 26, 2014
Obesity, cholesterol metabolism, and breast cancer pathogenesisDonald P McDonnell, Sunghee Park, Matthew T Goulet, et al.
Science (New York, N.Y.)|December 23, 2006
The heartbeat of the Oligocene climate systemHeiko Pälike, Richard D Norris, Jens O Herrle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 3, 2020
Corrigendum to: "MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma" [Biochim. Biophys. Acta, Gene Regul. Mech. 1861 (2018) 235-245]F Ferrucci, R Ciaccio, S Monticelli, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Journal of the National Cancer Institute|September 18, 2003
Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastomaCatherine A Burkhart, Andy J Cheng, Janice Madafiglio, et al.
Pageof 54

Showing results (361-370 of 531) with videos related to

Sort By:
Pageof 54
Alcoholism, Clinical and Experimental Research|April 9, 1999
Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis geneP S Haber, M D Norris, M V Apte, et al.
Cardiology in the Young|October 14, 2024
Physical activity in the Fontan population: provider recommendations and patient actionsAlyson R Pierick, Darren Marshall, Sunkyung Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials GroupM E Trudeau, E A Eisenhauer, B P Higgins, et al.
Cancer Research|July 26, 2014
Obesity, cholesterol metabolism, and breast cancer pathogenesisDonald P McDonnell, Sunghee Park, Matthew T Goulet, et al.
Science (New York, N.Y.)|December 23, 2006
The heartbeat of the Oligocene climate systemHeiko Pälike, Richard D Norris, Jens O Herrle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 3, 2020
Corrigendum to: "MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma" [Biochim. Biophys. Acta, Gene Regul. Mech. 1861 (2018) 235-245]F Ferrucci, R Ciaccio, S Monticelli, et al.
Blood|May 16, 2002
The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseRichard B Lock, Natalia Liem, Monica L Farnsworth, et al.
Journal of the National Cancer Institute|September 18, 2003
Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastomaCatherine A Burkhart, Andy J Cheng, Janice Madafiglio, et al.
Pageof 54